Physician profile
Renata Ford
NPI 1972685907
$1,132.29
in general payments reported to CMS, 2019-2025
9 companies · $48.85 in 2025
The $48.85 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $348 · 2020: $136 · 2021: $124 · 2022: $386 · 2023: $75.14 · 2024: $15.11 · 2025: $48.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $139.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $369.84 | 2019-2022 | |
| Medtronic Vascular, INC. | $206.56 | 2019 | |
| Abiomed | $187.84 | 2020-2024 | Impella |
| Getinge USA Sales, LLC | $114.82 | 2022 | |
| Medtronic, INC. | $100.51 | 2022-2023 | Corevalve Evolut R |
| Atricure, INC. | $75.35 | 2021-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Zimmer Biomet Holdings, INC. | $49.14 | 2023 | Sternalock Blu System |
| Abbott Laboratories | $14.51 | 2021 | |
| Bolton Medical INC | $13.72 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renata Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.